Press

Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine…

Approximately 15,000 Americans will be diagnosed with glioblastoma this year. Although considered a rare cancer, doctors are seeing an increase in cases of the aggressive and deadly brain cancer that’s notoriously hard to treat. A local organization that’s helping enroll…

After he was not accepted into the University of Hong Kong, plan B for W.K. Alfred Yung, MD, was to leave his country and immigrate to the United States to attend the University of Minnesota in Minneapolis—a move he considers…

Together with the National Foundation for Cancer Research (NFCR) and the AIM-HI Accelerator Fund (AIM-HI) we hosted a charitable hybrid combo event on October 30 2021 – our first big project in the United States. While the live event took place at…

National Foundation for Cancer Research Appoints Brain Cancer Charity CEO, Renowned Cancer Researcher, and Dermatology Professor as Newest Board Members FOR IMMEDIATE RELEASE January 31, 2022 Maryland – The National Foundation for Cancer Research (NFCR) has announced three new experts…

Rasio Therapeutics, a company whose cancer drug research technology was developed and applied in part with funding provided over many years by the National Foundation for Cancer Research to University of Maryland, Baltimore, researcher Curt Civin, has raised additional investment…

Insights from National Foundation for Cancer Research Chief Medical Officer Brian Leyland-Jones, along with such other authoritative sources as Johns Hopkins Medicine, the Mayo Clinic and the U.S. National Cancer Institute, are featured in this Eat This, Not That! overview…